AARD
Aardvark Therapeutics, Inc.
5.20$
+4.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.8% | -92.0% | +2,300.0% | +81.3% | -239.1% | – | -12,500.0% | – | +0.0% | -1,280.0% | – | – | |
| – | -4.2% | -2.9% | -19.4% | +168.5% | +19.3% | +34.7% | +172.1% | +136.6% | +5.4% | +26.8% | -2.7% | – | |
| – | – | -146.0% | – | -108.2% | – | -389.2% | – | -122.8% | – | – | -492.0% | – | |
| – | – | – | +1,760.0% | -94.6% | +20.0% | -100.0% | – | -95.6% | -100.0% | – | – | – | |
| – | – | – | +1,760.0% | -94.6% | +237,800.0% | +846.8% | – | +210.8% | -16.9% | +40.9% | -16.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -99.9% | -1,684.4% | – | -100.1% | – | -182.6% | – | +6,450.0% | – | |
| – | – | – | – | -105.0% | – | – | – | – | -41.6% | +98.1% | -25.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.